IDEAYA Biosciences Announces Participation in Upcoming December 2024 Investor Relations Events
IDYA Stock | USD 27.19 0.58 2.09% |
About 62% of Ideaya Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ideaya Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ideaya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ideaya Biosciences stock news signals to limit their universe of possible portfolio assets.
Ideaya |
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events.
Read at finance.yahoo.com
Ideaya Biosciences Fundamental Analysis
We analyze Ideaya Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ideaya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ideaya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Ideaya Biosciences is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Ideaya Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ideaya Biosciences stock to make a market-neutral strategy. Peer analysis of Ideaya Biosciences could also be used in its relative valuation, which is a method of valuing Ideaya Biosciences by comparing valuation metrics with similar companies.
Peers
Ideaya Biosciences Related Equities
XFOR | X4 Pharmaceuticals | 13.43 | ||||
KROS | Keros Therapeutics | 3.53 | ||||
PTGX | Protagonist Therapeutics | 2.72 | ||||
ABOS | Acumen Pharmaceuticals | 0.46 | ||||
DAWN | Day One | 0.45 | ||||
MLTX | MoonLake Immunotherapeuti | 0.58 | ||||
INZY | Inozyme Pharma | 0.67 | ||||
RNA | Avidity Biosciences | 1.44 | ||||
RVMD | Revolution Medicines | 1.82 | ||||
VRNA | Verona Pharma | 1.87 | ||||
AMLX | Amylyx Pharmaceuticals | 3.10 | ||||
TERN | Terns Pharmaceuticals | 3.18 | ||||
MGTX | MeiraGTx Holdings | 3.40 | ||||
SNDX | Syndax Pharmaceuticals | 3.98 | ||||
SWTX | SpringWorks Therapeutics | 4.52 | ||||
VTYX | Ventyx Biosciences | 7.64 | ||||
ANAB | AnaptysBio | 32.83 |
Complementary Tools for Ideaya Stock analysis
When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |